Albrecht, V.;Richter, A.;Pfeiffer, S.;Gebauer, M.;Lindner, S.;Gieser, E.;Schuller, U.;Schichor, C.;Gildehaus, F. J.;Bartenstein, P.;Tonn, J. C.;Skerra, A.;Glass, R.
Anticalins directed against the fibronectin extra domain B as diagnostic tracers for glioblastomas
Int J Cancer
2016
138
5
1269-80

Barinka, C.;Ptacek, J.;Richter, A.;Novakova, Z.;Morath, V.;Skerra, A.
Selection and characterization of Anticalins targeting human prostate-specific membrane antigen (PSMA)
Protein Eng Des Sel
2016
29
3
105-15

Bolze, F.;Bast, A.;Mocek, S.;Morath, V.;Yuan, D.;Rink, N.;Schlapschy, M.;Zimmermann, A.;Heikenwalder, M.;Skerra, A.;Klingenspor, M.
Treatment of diet-induced lipodystrophic C57BL/6J mice with long-acting PASylated leptin normalises insulin sensitivity and hepatic steatosis by promoting lipid utilisation
Diabetologia
2016
59
9
2005-12

Bolze, F.;Morath, V.;Bast, A.;Rink, N.;Schlapschy, M.;Mocek, S.;Skerra, A.;Klingenspor, M.
Long-acting PASylated leptin ameliorates obesity by promoting satiety and preventing hypometabolism in leptin-deficient Lep(ob/ob) mice
Endocrinology
2016
157
1
233-44

Chhabra, K. H.;Adams, J. M.;Jones, G. L.;Yamashita, M.;Schlapschy, M.;Skerra, A.;Rubinstein, M.;Low, M. J.
Reprogramming the body weight set point by a reciprocal interaction of hypothalamic leptin sensitivity and Pomc gene expression reverts extreme obesity
Mol Metab
2016
5
10
869-81

Gande, S. L.;Saxena, K.;Sreeramulu, S.;Linhard, V.;Kudlinzki, D.;Heinzlmeir, S.;Reichert, A. J.;Skerra, A.;Kuster, B.;Schwalbe, H.
Expression and Purification of EPHA2 Tyrosine Kinase Domain for Crystallographic and NMR Studies
Chembiochem
2016
17
23
2257-2263

Gille, H.;Hulsmeyer, M.;Trentmann, S.;Matschiner, G.;Christian, H. J.;Meyer, T.;Amirkhosravi, A.;Audoly, L. P.;Hohlbaum, A. M.;Skerra, A.
Functional characterization of a VEGF-A-targeting Anticalin, prototype of a novel therapeutic human protein class
Angiogenesis
2016
19
1
79-94

Jarasch, A.;Kopp, M.;Eggenstein, E.;Richter, A.;Gebauer, M.;Skerra, A.
ANTICALIgN: visualizing, editing and analyzing combined nucleotide and amino acid sequence alignments for combinatorial protein engineering
Protein Eng Des Sel
2016
29
7
263-70

Kuhn, N.;Schmidt, C. Q.;Schlapschy, M.;Skerra, A.
PASylated Coversin, a C5-specific complement inhibitor with extended pharmacokinetics, shows enhanced anti-hemolytic activity in vitro
Bioconjug Chem
2016
27
10
2359-2371

Lerchner, A.;Daake, M.;Jarasch, A.;Skerra, A.
Fusion of an alcohol dehydrogenase with an aminotransferase using a PAS linker to improve coupled enzymatic alcohol-to-amine conversion
Protein Eng Des Sel
2016
29
12
557-562